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SUMM A R Y
We report a chain of 10 kidney transplantations, initiated in July 2007 by a single 
altruistic donor (i.e., a donor without a designated recipient) and coordinated over 
a period of 8 months by two large paired-donation registries. These transplanta-
tions involved six transplantation centers in five states. In the case of five of the 
transplantations, the donors and their coregistered recipients underwent surgery 
simultaneously. In the other five cases, “bridge donors” continued the chain as 
many as 5 months after the coregistered recipients in their own pairs had received 
transplants. This report of a chain of paired kidney donations, in which the trans-
plantations were not necessarily performed simultaneously, illustrates the potential 
of this strategy.
Paired kidney donation is an evolving strategy for overcoming the barriers that confront patients with end-stage renal disease when the only living potential donors who are willing to donate to them are deemed to be 
unsuitable as donors for them owing to an incompatibility of blood type, of HLA 
crossmatch, or of both. In the most basic form of paired donation, the incompati-
bility problems with two donor–recipient pairs can be solved by exchanging 
donors.1-3 Using advanced software, several organizations have arranged paired 
kidney donations involving three or more pairs.4,5 Recent reports describe simulta-
neously performed “domino transplantations” initiated by altruistic donors and 
terminated when the last paired donor in the chain donates a kidney to an unpaired 
recipient on the deceased-donor waiting list.6,7
Even in two-way paired donations, it is possible that after one donor has given 
a kidney to the other pair’s recipient, that recipient’s coregistered donor will fail to 
donate a kidney in return. To avoid this possibility, paired-donation transplanta-
tions have been performed simultaneously. On the other hand, when an altruistic 
donation (also termed a nondirected donation8) initiates a chain of transplanta-
tions, each subsequent donor makes the donation only after the coregistered recipi-
ent in his or her pair has already received a transplant. Thus, although reneging 
in the middle of a chain would still be problematic, it would not irreparably harm 
the remaining pairs in the chain.7 This strategy allows for chains of transplanta-
tions that are not performed simultaneously, an approach that may help increase 
the number of transplantations performed. This report describes clusters of simul-
taneously performed transplantations, or single transplantations, in which the 
donor at the end of each cluster or single transplantation served as a “bridge donor,” 
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thus extending the interrupted chain at a later 
time. We refer to this type of arrangement as a 
“nonsimultaneous, extended, altruistic-donor” 
(NEAD) chain.
C a se R eport
In 2006, a 28-year-old white man from Michigan 
was registered as an altruistic donor at a New 
York transplantation center that participates in 
the Alliance for Paired Donation (APD), a 25-state 
coalition of more than 70 transplantation pro-
grams that pool patients into a single registry 
with the aim of increasing opportunities for 
paired donations. In April 2007, the APD match-
ing software found a match for the donor, and 
this altruistic donor started a NEAD chain.
Transplantation 1
The altruistic donor was matched with a 53-year-
old white woman with polycystic kidney disease 
whose husband was a willing but incompatible 
donor for her owing to a positive crossmatch. 
The altruistic donor traveled to Phoenix, Arizona, 
and on July 18, 2007, donated a kidney to this 
first recipient (Fig. 1).
Transplantation 2
Eight days after the first transplantation, the 
Arizona woman’s husband (Donor 2) traveled to 
Toledo, Ohio, and donated his kidney to a 32-
year-old woman (Recipient 2) whose ABO-incom-
patible donor — her mother (Donor 3) — had 
already been found to be a probable match for a 
recipient in Columbus, Ohio.
Transplantations 3 and 4
Two months later, Donor 3 traveled to Columbus 
for her final evaluation and on September 13, 
2007, donated a kidney to a recipient at Ohio 
State University (Recipient 3). Simultaneously, that 
recipient’s coregistered donor (Donor 4) donated 
a kidney to another recipient (Recipient 4) at the 
same hospital. The sister of Recipient 4 became a 
“bridge donor,” but her blood type was B, and 
she was therefore more difficult to match. At the 
time, the APD registry included only three poten-
tial recipients with blood group B, all of whom 
were too highly sensitized and had donor-specific 
antibodies that were too high for them to receive 
a transplant from this donor.
Transplantation 5
Since no matches for the bridge donor (Donor 5) 
were found during the next 3 months, the APD 
contacted the Incompatible Kidney Transplanta-
tion Program at Johns Hopkins Hospital in Balti-
more, a single-center registry. A highly sensitized 
patient (panel-reactive antibody level, 82%) with 
blood type B who was registered in that program 
36p6
AUTHOR:
FIGURE:
JOB:
4-C
H/T
RETAKE
SIZE
ICM
CASE
EMail Line
H/T
Combo
Revised
AUTHOR, PLEASE NOTE: 
Figure has been redrawn and type has been reset.
Please check carefully.
REG F
Enon
1st
2nd
3rd
Rees
1 of 3
03-12-09
ARTIST: ts
36011 ISSUE:
O O A A B A A A A A
July
2007
AZ
July
2007
OH
Sept.
2007
OH
Sept.
2007
OH
Feb.
2008
MD
Feb.
2008
MD
Feb.
2008
MD
Feb.
2008
NC
March
2008
MD
1 2 3 4 5 6 7 8 9 10
March
2008
OH
62%
White
Wife–
Husband
0%
White
Daughter–
Mother
23%
White
Mother–
Daughter
0%
White
Brother–
Sister
82%
White
Husband–
Wife
78%
Hispanic
Daughter–
Father
64%
White
Wife–
Husband
100%
White
Brother–
Brother
46%
Black
Mother–
Daughter
3%
White
Friend–
Friend
Date
Transplant No.
Recipient’s State
Recipient’s PRA
Recipient’s Race
or Ethnic Group
Recipient–Donor
Relationship
Recipient’s Sex
and ABO Type
Donor’s Sex and
ABO Type
AO AO B A A A AB A AB
Figure 1. A Nonsimultaneous, Extended, Altruistic-Donor Chain.
In less than 1 year, 10 patients (5 with panel-reactive antibodies [PRAs] >60%) were given a transplant; an 11th transplantation is possible. 
The initiating donor was an unpaired altruistic donor from Michigan. To date, none of the bridge donors have reneged. The recipient of 
transplant 6 required desensitization of HLA donor-specific antibodies by T-cell and B-cell flow cytometry. The recipient of transplant 9 had 
an anti-B antibody titer of 1:8 (as assessed with the use of an antihuman globulin reagent) and required desensitization to blood group.
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had only a one-antigen mismatch with  the donor 
from Ohio State University and a negative cross-
match; this patient became Recipient 5, receiving 
the transplant at Johns Hopkins Hospital on Feb-
ruary 12, 2008 — 5 months after the donor’s 
brother (Recipient 4) had received a transplant.
Transplantations 6, 7, and 8
After the fifth transplantation, computerized 
match runs at both Johns Hopkins Hospital and 
the APD revealed that the bridge donor from the 
fifth transplantation (Donor 6) could donate a 
kidney to a Hispanic woman at Johns Hopkins 
Hospital for the sixth transplantation. Donor 7 
from that pair could donate a kidney to another 
recipient at Johns Hopkins Hospital, and Donor 8 
from that pair could donate a kidney to a recipi-
ent in an APD pair at Wake Forest University in 
North Carolina. On February 29, 2008, nephrec-
tomies, performed laparoscopically, were begun 
simultaneously in Donors 6, 7, and 8. The sixth 
transplantation was the first that required desen-
sitization of the recipient because of a weakly 
positive T-cell and B-cell crossmatch on flow cy-
tometry. The eighth transplantation was the first 
in which the donor did not travel to the recipient’s 
transplantation center; instead, the donated or-
gan was shipped. Donor 8’s kidney was removed 
at Johns Hopkins Hospital and was shipped by 
commercial airline to Wake Forest University. The 
cold-ischemia time for the kidney (the time elapsed 
between procurement of the kidney and trans-
plantation) was approximately 10 hours.
Transplantations 9 and 10
Before transplantations 6, 7, and 8 were per-
formed, the Johns Hopkins software had deter-
mined that the bridge donor (Donor 9) who was 
expected to emerge from the eighth transplanta-
tion had no unacceptable antigens for another 
Johns Hopkins recipient (Recipient 9), who had a 
panel-reactive antibody level of 100%. However, 
the donor had blood type AB, whereas the pro-
spective recipient had blood type A. The prospec-
tive recipient had an anti-B antibody titer of only 
1:8 (as assessed with the use of an antihuman 
globulin reagent), so desensitization across the 
blood-group barrier was accomplished with only 
two plasmapheresis treatments. On March 18, 
2008, Donor 9’s kidney was removed at Wake 
Forest University, shipped to Johns Hopkins Hos-
pital on a charter flight, and transplanted into 
Recipient 9 after a cold-ischemia time of approx-
imately 6 hours. Recipient 9’s coregistered donor 
(Donor 10) was a 40-year-old white man in Balti-
more. With the use of the APD software, he was 
matched with Recipient 10 at the University of 
Toledo Medical Center. On the same day that 
Transplantation 9 was performed, Donor 10’s kid-
ney was removed at Johns Hopkins Hospital, 
f lown by commercial airline to Toledo, Ohio, and 
transplanted into a 60-year-old black woman 
(Recipient 10) after a cold-ischemia time of ap-
proximately 12 hours.
Another Bridge Donor
Before transplantations 9 and 10 were performed, 
Donor 11 (the daughter of Recipient 10) was 
matched with the recipient of a compatible pair. 
Even though the donor in that pair was a suitable 
donor for his own coregistered recipient, the two 
friends who made up that pair chose to partici-
pate in the chain because they liked the idea of 
helping others and because the outcome for the 
recipient in the pair might be improved, since the 
recipient would receive a kidney from a 23-year-
old donor who was negative for cytomegalovirus 
instead of the kidney that would have been do-
nated by the 48-year-old friend, who was positive 
for cytomegalovirus. 
Discussion
The most controversial issue in the case of a 
NEAD chain is whether paired donors can or 
should be trusted to donate a kidney after their 
own coregistered recipients have received trans-
plants. Until now, paired donations in the United 
States have been performed simultaneously to 
eliminate the possibility of a donor reneging.2 As 
shown in Figure 2A, Pair 2 is harmed if the do-
nor in Pair 1 does not donate after the donor in 
Pair 2 has donated, not only because the recipient 
in Pair 2 will not have received the promised trans-
plant from the donor in Pair 1 but also because 
the recipient in Pair 2 will have lost the “bargain-
ing chip” of a living, willing donor who, although 
incompatible with him or her, may be a compati-
ble donor for someone else. The situation is dif-
ferent when paired donations are arranged in a 
chain initiated by an altruistic donor (Fig. 2B). In 
this type of chain, the two recipient–donor pairs 
are unchanged, but now there is an altruistic do-
nor who is a suitable donor for the recipient in 
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Pair 1. If for some reason the altruistic donor 
donates to the recipient in Pair 1, but the donor 
in Pair 1 then fails to donate to the recipient in 
Pair 2, the outcome will be unfair, but Pair 2 will 
not have been irreparably harmed and can still 
enter into a new paired donation or chain. Thus, 
we suggest that when paired donations are initi-
ated by an altruistic donor, the transplantations 
do not necessarily have to be performed simulta-
neously.7
It is not possible to predict the rate at which 
potential donors in NEAD chains will renege on 
their agreement to donate, though it seems like-
ly that the risk will be increased if the outcome 
of the coregistered recipient’s transplantation is 
poor or if the bridge donor has to wait a very 
long time to donate. Furthermore, a bridge do-
nor could be forced to break the chain if he or 
she were found to be medically unsuitable after 
the coregistered recipient had received a trans-
plant. Even if a NEAD chain were broken because 
of some complication that precluded a proposed 
transplantation without eliminating the bridge 
donor from the pool, the chain could still be 
extended by finding another recipient. A second 
NEAD chain that has generated five transplanta-
tions since its initiation in December 2007 was 
interrupted because of a last-minute positive 
crossmatch, but an alternative recipient was found. 
It was not until 10 months later that the chain 
was continued, when a transplantation from the 
new recipient’s bridge donor was performed.
In addition to allowing nonsimultaneous 
transplantations, the NEAD chain described here 
included other controversial elements. First, three 
kidneys from living donors were shipped (two 
on commercial airlines) instead of having the 
donors travel to the matched recipient’s hospi-
tal.9 Though charter flights may decrease cold-
ischemia times, a recent study showed that up to 
8 hours of cold-ischemia time did not appear to 
affect the 10-year graft survival of kidney trans-
plants from living donors.10 (In the case of two 
of the three kidneys that were transported by 
airplane in this chain, the cold-ischemia time 
was longer than 8 hours; however, both kidneys 
are functioning well, suggesting that there were 
no short-term negative effects of the prolonged 
cold ischemia.) Second, two highly sensitized 
recipients with formidable HLA barriers against 
their coregistered donors were matched with 
donors with whom they had minor ABO or HLA 
incompatibilities that required short courses of 
plasmapheresis. Third, even presenting the op-
tion of paired donation to compatible pairs is 
thought to be controversial, since the pair is be-
ing asked to consider the needs of others and 
not just their own needs. However, in addition to 
helping potential recipients in incompatible pairs 
to obtain transplants, NEAD chains may also 
make it possible for potential recipients in com-
patible pairs to receive higher-quality trans-
plants.11-13
The allocation of organs in the United States 
has followed the federal mandate specified in 
the National Organ Transplant Act, which calls 
for the development of “a system to allocate 
donated organs equitably among transplant pa-
tients, according to established medical crite-
ria.”14 The United Network for Organ Sharing 
(UNOS) has interpreted equitable to mean “bal-
anced between justice and utility.”15 Consequently, 
in May 2001, a consensus conference on nondi-
rected kidney donations from living donors rec-
ommended that altruistically donated organs 
should be allocated to the patients on the de-
ceased-donor waiting list who have the highest 
ranking, according to the UNOS point system.16 
NEAD chains favor utility over justice, since 
greater weight is placed on generating more than 
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Figure 2. Consequences of a Donor’s Reneging in a Conventional Paired 
Donation and in a Nonsimultaneous, Extended, Altruistic-Donor Chain.
Reneging in a conventional two-way paired donation (Panel A) permanently 
harms Pair 2 because the recipient in that pair does not receive a kidney and 
has lost the opportunity to participate in a future paired donation. Reneg-
ing in a paired donation that is part of a nonsimultaneous, extended, altru-
istic-donor (NEAD) chain (Panel B) does not permanently harm Pair 2, 
since the donor in that pair has not yet donated a kidney, and the pair can 
be matched again. In this example, squares are compatible with squares 
but not with circles, and circles are compatible with circles but not with 
squares. A black arrow represents a donation by a living donor, a broken 
red arrow represents reneging on a donation, and the red X represents a 
donor who has donated a kidney and is no longer able to help the recipient 
in their pair through paired donation. AD denotes altruistic donor, D donor, 
and R recipient.
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one transplant from the altruistic donor’s gift. 
However, NEAD chains should still benefit pa-
tients on the list who do not have willing do-
nors, because patients who are enrolled in paired-
donation programs are generally concomitantly 
added to the deceased-donor waiting list. Each 
subsequent transplantation in the chain would 
take a candidate for a kidney from a deceased 
donor off the waiting list, resulting in a shorter 
overall waiting time.
Defining the “quality” points assigned to the 
allocation of kidneys from living donors is a 
nascent field as compared with the careful scru-
tiny that UNOS has given to deceased-donor allo-
cation.17 The APD scoring rubric incorporates all 
four factors that are used by UNOS (i.e., waiting 
time, HLA match, level of sensitization, and the 
candidate’s age, with priority given to children 
over adults) but also incorporates additional fac-
tors that are unique to paired donation (e.g., the 
distance the donor would have to travel). All 
feasible matches are identified, and points are 
assigned. A flexible, integer-programming opti-
mization algorithm then identifies the non–
mutually exclusive transplantations that result in 
the greatest sum of points when chains and ex-
changes that allow for more than two transplan-
tations at a time are used,12,18,19 in contrast to 
algorithms that focus on two-way exchanges.20,21
Wider adoption of the concepts we propose 
might allow substantially more kidney transplan-
tations from living donors to be performed. 
Chains of matches (as in Fig. 2B) may be con-
siderably more likely to occur than sets of recip-
rocal matches (as in Fig. 2A).7,12,19 Furthermore, 
simulations show that paired donations involv-
ing more than two pairs will yield substantially 
more transplantations than conventional two-
way exchanges,5 and because NEAD chains avoid 
otherwise insurmountable logistic barriers (e.g., 
having 20 simultaneously available operating 
rooms to perform 10 simultaneous transplanta-
tions), even longer chains and even greater num-
bers of transplantations could be arranged.
In addition to increasing the quantity of liv-
ing-donor transplantations, NEAD chains may 
improve the quality of the matches. To find two-
way exchanges between pairs, the computer must 
seek pairs with reciprocal compatibilities, and as 
shown in Figure 3, such pairs do not necessarily 
result in the best possible matches that could 
have been arranged. If an important benefit for 
an altruistic donor is psychological, then argu-
ably there is more psychological benefit to be 
derived from helping a chain of many patients 
than from helping only one patient.22
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Figure 3. Feasible Matches in a Conventional Paired Donation and in a Nonsimultaneous, Extended, Altruistic-Donor Chain.
Panel A shows feasible matches for the donor in incompatible pair 1 (solid arrows), which are ranked according to the quality of the 
match. Only the donor in incompatible pair 4 is able to donate a kidney to the recipient in incompatible pair 1 (broken arrow). Panel B 
shows all feasible matches for the donor in incompatible pair 4 (arrows), ranked according to the quality of the match. When potential 
transplantations are limited to conventional two-way paired donations, the only feasible match in this pool is between pairs 1 and 4, but 
this match is actually the least desirable match for their donors among the pool of potential recipients. Panel C shows how an altruistic 
donor can start a chain of transplantations in which every donor is matched to the recipient for whom that donor provides the maxi-
mum benefit. AD denotes altruistic donor, and BD bridge do or.
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Although many challenges remain in maximiz-
ing the benefits that can be achieved with paired 
donation, we believe that this report of a chain of 
paired kidney donations in which the transplan-
tations were not necessarily performed simulta-
neously illustrates the potential of this approach.
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